Case report: Illustrating associated malignancies in Paget’s disease using contrast-enhanced mammography

IntroductionThe following presentation explores the diagnostic potential of Contrast-Enhanced Mammography (CEM) in evaluating and managing Paget’s Disease (PD) of the breast, particularly as an alternative or complementary tool to Magnetic Resonance Imaging (MRI) in cases where MRI is contraindicate...

Full description

Saved in:
Bibliographic Details
Main Authors: Luciano Mariano, Luca Nicosia, Anna Bozzini, Filippo Pesapane, Francesca Magnoni, Giovanni Mazzarol, Lorenza Meneghetti, Adriana Sorce, Enrico Cassano
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1497506/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555085295878144
author Luciano Mariano
Luca Nicosia
Luca Nicosia
Anna Bozzini
Filippo Pesapane
Francesca Magnoni
Giovanni Mazzarol
Lorenza Meneghetti
Adriana Sorce
Enrico Cassano
author_facet Luciano Mariano
Luca Nicosia
Luca Nicosia
Anna Bozzini
Filippo Pesapane
Francesca Magnoni
Giovanni Mazzarol
Lorenza Meneghetti
Adriana Sorce
Enrico Cassano
author_sort Luciano Mariano
collection DOAJ
description IntroductionThe following presentation explores the diagnostic potential of Contrast-Enhanced Mammography (CEM) in evaluating and managing Paget’s Disease (PD) of the breast, particularly as an alternative or complementary tool to Magnetic Resonance Imaging (MRI) in cases where MRI is contraindicated or inconclusive.Clinical casesTwo clinical cases of PD diagnosed at our Breast Imaging Division between January and May 2024 were analyzed using CEM. These cases involved imaging techniques, including Digital Mammography (DM), Breast Ultrasound (US), MRI and CEM, alongside histopathological confirmation through nipple-areolar complex (NAC) punch biopsies. CEM identified disease extensions and NAC involvement that was not evident in conventional imaging in both cases. CEM findings influenced surgical decisions, leading to total mastectomies with reconstruction instead of conservative approaches. The cases highlighted CEM’s sensitivity and ability to delineate the disease extent comparable to MRI.Discussion and conclusionsPD often presents diagnostic challenges due to frequent associations with underlying malignancies that are undetectable by standard imaging. While MRI is the gold standard, its limitations, such as costs, contraindications, and false positives, warrant alternative methods. CEM demonstrated utility in diagnosing and staging PD, offering benefits in patient acceptability, cost, and sensitivity comparable to MRI. CEM is a promising diagnostic and planning tool for PD management, especially in MRI-infeasible cases. More extensive multicentric studies will be needed to validate CEM’s role in this context. CEM could enhance PD diagnostic workflows and treatment strategies, significantly impacting clinical outcomes.
format Article
id doaj-art-582ea66b89e74076a0c05f71cf6d737f
institution Kabale University
issn 2234-943X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-582ea66b89e74076a0c05f71cf6d737f2025-01-08T06:12:16ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-01-011410.3389/fonc.2024.14975061497506Case report: Illustrating associated malignancies in Paget’s disease using contrast-enhanced mammographyLuciano Mariano0Luca Nicosia1Luca Nicosia2Anna Bozzini3Filippo Pesapane4Francesca Magnoni5Giovanni Mazzarol6Lorenza Meneghetti7Adriana Sorce8Enrico Cassano9Breast Imaging Division, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, ItalyBreast Imaging Division, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, ItalyDepartment of Biotechnology and Life Sciences, University of Insubria, Varese, ItalyBreast Imaging Division, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, ItalyBreast Imaging Division, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, ItalyDivision of Breast Surgery, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, ItalyDivision of Pathology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, ItalyBreast Imaging Division, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, ItalyPostgraduation School in Radiodiagnostics, Università degli Studi di Milano, Milan, ItalyBreast Imaging Division, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, ItalyIntroductionThe following presentation explores the diagnostic potential of Contrast-Enhanced Mammography (CEM) in evaluating and managing Paget’s Disease (PD) of the breast, particularly as an alternative or complementary tool to Magnetic Resonance Imaging (MRI) in cases where MRI is contraindicated or inconclusive.Clinical casesTwo clinical cases of PD diagnosed at our Breast Imaging Division between January and May 2024 were analyzed using CEM. These cases involved imaging techniques, including Digital Mammography (DM), Breast Ultrasound (US), MRI and CEM, alongside histopathological confirmation through nipple-areolar complex (NAC) punch biopsies. CEM identified disease extensions and NAC involvement that was not evident in conventional imaging in both cases. CEM findings influenced surgical decisions, leading to total mastectomies with reconstruction instead of conservative approaches. The cases highlighted CEM’s sensitivity and ability to delineate the disease extent comparable to MRI.Discussion and conclusionsPD often presents diagnostic challenges due to frequent associations with underlying malignancies that are undetectable by standard imaging. While MRI is the gold standard, its limitations, such as costs, contraindications, and false positives, warrant alternative methods. CEM demonstrated utility in diagnosing and staging PD, offering benefits in patient acceptability, cost, and sensitivity comparable to MRI. CEM is a promising diagnostic and planning tool for PD management, especially in MRI-infeasible cases. More extensive multicentric studies will be needed to validate CEM’s role in this context. CEM could enhance PD diagnostic workflows and treatment strategies, significantly impacting clinical outcomes.https://www.frontiersin.org/articles/10.3389/fonc.2024.1497506/fullcontrast enhanced mammographyCEMbreast cancerbreast imagingPaget carcinoma
spellingShingle Luciano Mariano
Luca Nicosia
Luca Nicosia
Anna Bozzini
Filippo Pesapane
Francesca Magnoni
Giovanni Mazzarol
Lorenza Meneghetti
Adriana Sorce
Enrico Cassano
Case report: Illustrating associated malignancies in Paget’s disease using contrast-enhanced mammography
Frontiers in Oncology
contrast enhanced mammography
CEM
breast cancer
breast imaging
Paget carcinoma
title Case report: Illustrating associated malignancies in Paget’s disease using contrast-enhanced mammography
title_full Case report: Illustrating associated malignancies in Paget’s disease using contrast-enhanced mammography
title_fullStr Case report: Illustrating associated malignancies in Paget’s disease using contrast-enhanced mammography
title_full_unstemmed Case report: Illustrating associated malignancies in Paget’s disease using contrast-enhanced mammography
title_short Case report: Illustrating associated malignancies in Paget’s disease using contrast-enhanced mammography
title_sort case report illustrating associated malignancies in paget s disease using contrast enhanced mammography
topic contrast enhanced mammography
CEM
breast cancer
breast imaging
Paget carcinoma
url https://www.frontiersin.org/articles/10.3389/fonc.2024.1497506/full
work_keys_str_mv AT lucianomariano casereportillustratingassociatedmalignanciesinpagetsdiseaseusingcontrastenhancedmammography
AT lucanicosia casereportillustratingassociatedmalignanciesinpagetsdiseaseusingcontrastenhancedmammography
AT lucanicosia casereportillustratingassociatedmalignanciesinpagetsdiseaseusingcontrastenhancedmammography
AT annabozzini casereportillustratingassociatedmalignanciesinpagetsdiseaseusingcontrastenhancedmammography
AT filippopesapane casereportillustratingassociatedmalignanciesinpagetsdiseaseusingcontrastenhancedmammography
AT francescamagnoni casereportillustratingassociatedmalignanciesinpagetsdiseaseusingcontrastenhancedmammography
AT giovannimazzarol casereportillustratingassociatedmalignanciesinpagetsdiseaseusingcontrastenhancedmammography
AT lorenzameneghetti casereportillustratingassociatedmalignanciesinpagetsdiseaseusingcontrastenhancedmammography
AT adrianasorce casereportillustratingassociatedmalignanciesinpagetsdiseaseusingcontrastenhancedmammography
AT enricocassano casereportillustratingassociatedmalignanciesinpagetsdiseaseusingcontrastenhancedmammography